Add like
Add dislike
Add to saved papers

Formation of hybrid ABX 3 perovskite compounds for solar cell application: first-principles calculations of effective ionic radii and determination of tolerance factors.

The development of hybrid organic-inorganic perovskite solar cells is one of the most rapidly growing fields in the photovoltaic community and is on its way to challenge polycrystalline silicon and thin film technologies. High power conversion efficiencies can be achieved by simple processing with low cost. However, due to the limited long-term stability and environmental toxicity of lead in the prototypic CH3 NH3 PbI3 , there is a need to find alternative ABX3 constitutional combinations in order to promote commercialization. The Goldschmidt tolerance factor and the octahedral factor were found to be necessary geometrical concepts to evaluate which perovskite compounds can be formed. It was figured out that the main challenge lies in estimating an effective ionic radius for the molecular cation. We calculated tolerance factors and octahedral factors for 486 ABX3 monoammonium-metal-halide combinations, where the steric size of the molecular cation in the A-position was estimated concerning the total charge density. A thorough inquiry about existing mixed organic-inorganic perovskites was undertaken. Our results are in excellent agreement with the reported hybrid compounds and indicate the potential existence of 106 ABX3 combinations hitherto not discussed in the literature, giving hints for more intense research on prospective individual candidates.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app